搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
zvra
/
财务摘要
Zevra Therapeutics Inc
ZVRA
添加自选
11.260
USD
-0.060
-0.53%
收盘 09-24 16:00(美东)
665.69M
总市值
5.33
市盈率 TTM
Zevra Therapeutics Inc
11.260
-0.060
-0.53%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
ZVRA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Zevra Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
665.69M
股息TTM
0.00
市盈率 TTM
5.33
每股收益TTM
2.11
营业收入
106.47M
净利润
-105.51M
净资产收益率
96.08%
总资产收益率
55.05%
Zevra Therapeutics Inc 财报日历
最新发布
8月 5, 2026
每股收益 / 预测值
0.14
/0.11
营业收入 / 预测值
39.66M
/33.88M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-89.60%
0.14
1232.36%
0.65
131.38%
0.21
98.60%
-0.01
386.77%
1.36
85.60%
-0.06
-30.09%
-0.67
-132.78%
-0.69
-526.55%
-0.48
-3.75%
-0.40
-408.33%
-0.51
--
-0.30
--
-0.08
--
-0.38
--
0.17
--
-0.94
--
--
--
--
--
--
--
--
营业收入
53.25%
39.66M
77.54%
36.22M
183.36%
34.13M
605.36%
26.06M
481.73%
25.88M
495.65%
20.40M
-6.79%
12.04M
27.63%
3.69M
-47.47%
4.45M
7.84%
3.42M
538.97%
12.92M
0.73%
2.90M
551.54%
8.47M
-19.90%
3.18M
-21.69%
2.02M
46.26%
2.87M
-89.15%
1.30M
-67.28%
3.96M
9.13%
2.58M
2.08%
1.96M
净利润
-87.64%
8.39M
1322.65%
37.89M
133.10%
11.83M
98.36%
-544.00K
474.94%
74.71M
81.36%
-3.10M
-79.67%
-35.74M
-220.49%
-33.23M
-674.39%
-19.93M
-25.76%
-16.62M
-445.95%
-19.89M
-56.70%
-10.37M
89.30%
-2.57M
-609.07%
-13.22M
312.73%
5.75M
-276.12%
-6.62M
-124.80%
-24.04M
96.10%
-1.86M
44.34%
-2.70M
41.54%
-1.76M
利润率
-92.36%
22.07%
788.66%
104.61%
112.01%
35.65%
99.77%
-2.09%
164.45%
288.66%
96.87%
-15.19%
-92.75%
-296.76%
-151.10%
-899.19%
-1374.28%
-447.85%
-16.62%
-485.31%
-154.14%
-153.96%
--
-358.10%
--
-30.38%
--
-416.15%
--
284.37%
--
-399.58%
--
--
--
--
--
--
--
--
毛利率
107.64%
95.36%
149.71%
213.48%
25.76%
94.62%
2371.13%
94.04%
404.96%
45.93%
70.04%
85.49%
-10.99%
75.24%
-104.36%
-4.14%
-116.37%
-15.06%
-47.66%
50.28%
-14.54%
84.53%
--
95.03%
--
92.01%
--
96.06%
--
98.91%
--
97.54%
--
--
--
--
--
--
--
--
资产负债率
-100.00%
0.00%
-100.00%
0.00%
-34.89%
21.75%
-26.19%
22.70%
-41.37%
23.68%
22.41%
34.79%
34.61%
33.41%
-2.59%
30.75%
235.27%
40.39%
134.51%
28.42%
123.52%
24.82%
--
31.57%
--
12.05%
--
12.12%
--
11.10%
--
10.71%
--
--
--
--
--
--
--
--
利润表
营业收入
53.25%
39.66M
77.54%
36.22M
183.36%
34.13M
605.36%
26.06M
481.73%
25.88M
495.65%
20.40M
-6.79%
12.04M
27.63%
3.69M
-47.47%
4.45M
7.84%
3.42M
538.97%
12.92M
0.73%
2.90M
551.54%
8.47M
-19.90%
3.18M
-21.69%
2.02M
46.26%
2.87M
-89.15%
1.30M
-67.28%
3.96M
9.13%
2.58M
2.08%
1.96M
营业利润
236.08%
16.78M
1072.51%
52.15M
160.42%
9.31M
115.17%
4.14M
48.19%
-12.33M
73.83%
-5.36M
-1.71%
-15.42M
-77.73%
-27.31M
-280.60%
-23.80M
-59.66%
-20.49M
-62.75%
-15.16M
-131.87%
-15.36M
11.99%
-6.25M
-590.21%
-12.83M
-227.69%
-9.31M
-198.20%
-6.63M
-221.79%
-7.10M
-126.71%
-1.86M
11.63%
-2.84M
-83.18%
-2.22M
净利润
-87.64%
8.39M
1322.65%
37.89M
133.10%
11.83M
98.36%
-544.00K
474.94%
74.71M
81.36%
-3.10M
-79.67%
-35.74M
-220.49%
-33.23M
-674.39%
-19.93M
-25.76%
-16.62M
-445.95%
-19.89M
-56.70%
-10.37M
89.30%
-2.57M
-609.07%
-13.22M
312.73%
5.75M
-276.12%
-6.62M
-124.80%
-24.04M
96.10%
-1.86M
44.34%
-2.70M
41.54%
-1.76M
资产负债表
流动资产
11.03%
251.30M
181.92%
229.97M
159.23%
223.01M
126.38%
225.12M
271.71%
226.34M
29.71%
81.57M
-1.05%
86.03M
-27.42%
99.44M
-41.13%
60.89M
-39.69%
62.89M
-6.35%
86.94M
60.94%
137.01M
18.29%
103.43M
-1.42%
104.28M
-19.31%
92.83M
-36.77%
85.13M
-35.80%
87.44M
20.58%
105.78M
1272.66%
115.06M
1553.12%
134.63M
流动负债总额
68.67%
48.63M
74.33%
47.03M
15.30%
39.28M
-24.27%
26.11M
-5.31%
28.83M
-9.81%
26.98M
-53.79%
34.06M
58.80%
34.48M
66.83%
30.45M
91.53%
29.91M
513.16%
73.72M
157.55%
21.71M
154.95%
18.25M
430.25%
15.62M
184.23%
12.02M
127.99%
8.43M
20.14%
7.16M
-30.51%
2.94M
-43.87%
4.23M
-94.78%
3.70M
总资产
18.12%
302.71M
61.30%
278.58M
59.85%
284.73M
41.02%
270.12M
77.47%
256.28M
14.16%
172.71M
3.37%
178.13M
37.82%
191.55M
36.86%
144.41M
41.92%
151.28M
49.41%
172.33M
16.25%
138.98M
-15.08%
105.52M
-15.20%
106.59M
-13.24%
115.34M
-12.85%
119.55M
-10.48%
124.26M
39.00%
125.71M
1086.02%
132.94M
1124.44%
137.19M
总负债
-38.83%
85.06M
-44.74%
72.78M
-6.06%
130.07M
12.46%
136.95M
24.23%
139.05M
28.52%
131.69M
25.35%
138.46M
70.29%
121.78M
202.36%
111.93M
191.17%
102.47M
174.65%
110.46M
177.64%
71.51M
47.93%
37.02M
736.49%
35.19M
590.71%
40.22M
372.69%
25.76M
207.66%
25.02M
-31.97%
4.21M
-92.50%
5.82M
-92.59%
5.45M
总权益
85.66%
217.65M
401.68%
205.80M
289.90%
154.66M
90.86%
133.16M
260.95%
117.23M
-15.97%
41.02M
-35.88%
39.67M
3.41%
69.77M
-52.59%
32.48M
-31.63%
48.82M
-17.65%
61.86M
-28.07%
67.47M
-30.97%
68.50M
-41.23%
71.40M
-40.91%
75.12M
-28.80%
93.79M
-24.05%
99.23M
44.21%
121.50M
291.41%
127.12M
311.36%
131.74M
现金流量表
经营净额
572.98%
17.03M
174.70%
6.14M
133.94%
5.52M
125.96%
4.71M
81.16%
-3.60M
49.14%
-8.22M
-0.57%
-16.25M
-291.98%
-18.14M
-119.54%
-19.11M
-299.63%
-16.16M
-262.12%
-16.16M
29.86%
-4.63M
-108.63%
-8.70M
-13.85%
-4.04M
-426.18%
-4.46M
-141.68%
-6.60M
-125.13%
-4.17M
-37.39%
-3.55M
19.92%
-848.00K
-159.75%
-2.73M
投资净额
163.54%
31.45M
655.25%
79.62M
104.15%
227.00K
85.41%
-4.58M
9351.16%
11.93M
-28.74%
10.54M
-151.69%
-5.47M
29.47%
-31.35M
-100.38%
-129.00K
184.27%
14.79M
16901.59%
10.59M
-16444.12%
-44.46M
202.89%
34.04M
-356.21%
-17.55M
99.59%
-63.00K
6900.00%
272.00K
-40739.51%
-33.08M
--
-3.85M
-59280.77%
-15.44M
--
-4.00K
融资净额
14.77%
1.58M
-3385.87%
-52.80M
219.85%
2.55M
-89.92%
6.53M
-90.99%
1.38M
32.05%
1.61M
-84.09%
796.00K
146.64%
64.77M
1511.99%
15.33M
132.45%
1.22M
2047.08%
5.00M
6520.29%
26.26M
-93.12%
951.00K
20.77%
-3.75M
91.05%
-257.00K
-121.06%
-409.00K
-65.23%
13.82M
-106.37%
-4.73M
-6139.13%
-2.87M
3907.84%
1.94M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Zevra Therapeutics Inc的总收入是多少?
根据Zevra Therapeutics Inc的FY2025财报,总收入达到了106.47M(同比变化23.61M)。
Zevra Therapeutics Inc的流动资产是多少?
根据Zevra Therapeutics Inc的FY2025财报,流动资产为223.01M(同比变化159.23)。
Zevra Therapeutics Inc的总资产是多少?
根据Zevra Therapeutics Inc的FY2025财报,Zevra Therapeutics Inc的总资产为284.73M(同比变化59.85)。
Zevra Therapeutics Inc的总负债是多少?
根据Zevra Therapeutics Inc的FY2025财报,Zevra Therapeutics Inc的总负债为130.07M(同比变化-6.06)。
Zevra Therapeutics Inc的总权益是多少?
根据Zevra Therapeutics Inc的FY2025财报,Zevra Therapeutics Inc的总权益为154.66M(同比变化289.90)。
Zevra Therapeutics Inc的净营业收入是多少?
根据Zevra Therapeutics Inc的FY2025财报,Zevra Therapeutics Inc的净营业收入为-4.23M(同比变化95.13)。
Zevra Therapeutics Inc的净投资是多少?
根据Zevra Therapeutics Inc的FY2025财报,Zevra Therapeutics Inc的净投资为18.13M(同比变化181.80)。
Zevra Therapeutics Inc的净融资是多少?
根据Zevra Therapeutics Inc的FY2025财报,Zevra Therapeutics Inc的净融资为12.06M(同比变化-85.31)。
Zevra Therapeutics Inc的每股收益(EPS)是多少?
根据Zevra Therapeutics Inc的FY2025财报,每股收益(EPS)为1.40(同比变化161.49)。
Zevra Therapeutics Inc的净利润是多少?
根据Zevra Therapeutics Inc的FY2025财报,净利润为77.58M(同比变化173.53)。
Zevra Therapeutics Inc的净利润率是多少?
根据Zevra Therapeutics Inc的FY2025财报,净利润率为78.17(同比变化117.49)。
Zevra Therapeutics Inc的毛利率是多少?
根据Zevra Therapeutics Inc的FY2025财报,毛利率为80.89(同比变化91.77)。
Zevra Therapeutics Inc的债务与资产比率是多少?
根据Zevra Therapeutics Inc的FY2025财报,债务与资产比率为21.75(同比变化-34.89)。
Zevra Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Zevra Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为79.85(同比变化138.42)。
Zevra Therapeutics Inc的资产回报率(ROA)是多少?
根据Zevra Therapeutics Inc的FY2025财报,资产回报率(ROA)为35.96(同比变化159.73)。
Zevra Therapeutics Inc的营业利润是多少?
根据Zevra Therapeutics Inc的FY2025财报,营业利润为-4.23M(同比变化95.13)。